Karin E. Smedby

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

Matthew J. Maurer, Vít Procházka, Tarec Christoffer El‐Galaly, Christopher R. Flowers et autres

PURPOSE: Although most patients with follicular lymphoma (FL) can expect an indolent course, progressive lymphoma remains the primary cause of death during the first decade after diagnosis. Progression of disease within 24 months (POD24) of starting first-line (1L) immunochemotherapy defines a high-risk …

us, cz, dk, se, ca, fr, au, gb (code pays fourni par la source)

Utilisation of healthcare in children born to lymphoma survivors in Sweden

Joshua P. Entrop, Viktor Wintzell, Caroline E. Dietrich, Ingrid Glimelius et autres

BACKGROUND AND PURPOSE: Advances in lymphoma treatment lead to a growing population of lymphoma survivors in childbearing ages who might be concerned about the impact of their disease on their children's health. In this study, we aim to explore healthcare utilisation patterns …

se, dk (code pays fourni par la source)

Increased risk of hip and other major osteoporotic fractures within 18 months of lymphoma diagnosis—a national registry study of 36,864 Swedish lymphoma patients

Catharina Lewerin, Hallgerður Lind Kristjánsdóttir, Joshua P. Entrop, Karin E. Smedby et autres

In this retrospective population cohort comprising 36,864 adult lymphoma patients, an increased risk of MOF, including hip fractures, was observed within 18 months of lymphoma diagnosis compared with the Swedish population and especially increased in the 51-60-year age group. PURPOSE: To explore …

se, is (code pays fourni par la source)

Shared genetic susceptibility between idiopathic inflammatory myopathies and common B cell lymphoma subtypes found primarily in the human leucocyte antigen region

Weng Ian, Anton Öberg Sysojev, Catherine Zhu, Karina Patasova et autres

Objectives To estimate shared genetic susceptibility between major subtypes of idiopathic inflammatory myopathies (IIM) and B cell lymphomas. Methods We paired summary statistics from genome-wide association studies (GWASs) of diffuse large B cell lymphoma, follicular lymphoma (FL), chronic lymphocytic leukaemia (CLL) and …

mo, se, us (code pays fourni par la source)

Increased mortality due to lymphoma and infections in patients with mycosis fungoides or Sézary syndrome: a Swedish nationwide population-based cohort study

Lina U. Ivert, Sara Ekberg, Karin E. Smedby, Hanna Brauner

This large population-based study confirms lymphoma as the leading cause of death in patients with mycosis fungoides/Sézary syndrome (MF/SS), particularly those with severe disease. Patients with MF/SS also had higher mortality from infections, although the absolute infection-related mortality was low. Mortality from …

se (code pays fourni par la source)

Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series

Gita Thanarajasingam, Ajay Major, Vishal Bhatnagar, Amylou C. Dueck et autres

us, se, dk, au, nl, ca, de (code pays fourni par la source)

ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker

Birna Þorvaldsdóttir, Larry Mansouri, Lesley‐Ann Sutton, Ferran Nadeu et autres

Despite the well-established adverse impact of del(11q) in chronic lymphocytic leukemia (CLL), the prognostic significance of somatic ATM mutations remains uncertain. We evaluated the effects of ATM aberrations (del(11q) and/or ATM mutations) on time-to-first-treatment (TTFT) in 3631 untreated patients with CLL, in …

se, es, de, gb, dk, gr, it, ch, cz, fr (code pays fourni par la source)

Temporal trends in relative survival of diffuse large B‐cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies

Sara Harrysson, Sandra Eloranta, Stefanie Antonilli, Mikkel Runason Simonsen et autres

se, dk (code pays fourni par la source)

Congestive heart failure after anthracycline‐containing treatment for Hodgkin lymphoma: A Swedish matched cohort study

Joachim Bæch, Tarec Christoffer El‐Galaly, Joshua P. Entrop, Ingrid Glimelius et autres

Abstract Introduction Congestive heart failure (CHF) is a known complication after anthracyclines and radiotherapy for classical Hodgkin lymphoma (cHL). Contemporary cHL treatment may be associated with less risk because radiotherapy use and techniques have changed substantially over time. Methods In this study, …

dk, se (code pays fourni par la source)

Evaluation of coverage, generalisability and validity of the U‐CAN lymphoma biobank in Sweden: A comparison with nationwide registers

E Forsgren, Sara Ekberg, Karin E. Smedby, Patrick Nylund et autres

Validation of biobanks and large cancer cohorts is essential in ensuring high-quality research results. We examined the coverage, generalisability and validity of the lymphoma collection of the Uppsala-Umeå Comprehensive Cancer Consortium (U-CAN) biobank in Sweden, one of the largest cancer biobanks in …

se (code pays fourni par la source)

Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study

C. Malinverni, Andrea Bernardelli, Ingrid Glimelius, Massimo Mirandola et autres

ABSTRACT: Patients with mantle cell lymphoma (MCL) who experience first relapse/refractoriness can be categorized into early or late progression-of-disease (POD) groups, with a threshold of 24 months from MCL diagnosis. Bruton tyrosine kinase inhibitors (BTKi) are the established standard treatment at first …

it, se, gb, es, pt, hr, de, dk, no, fi (code pays fourni par la source)

Secondary malignancies among mantle cell lymphoma patients

Kossi Abalo, Karin E. Smedby, Sara Ekberg, Sandra Eloranta et autres

Purpose With modern treatments, mantle cell lymphoma (MCL) patients more frequently experience long-lasting remission resulting in a growing population of long-term survivors. Follow-up care includes identification and management of treatment-related late-effects, such as secondary malignancies (SM). We conducted a population-based study to …

se (code pays fourni par la source)